Smart wearable device to improve walking for people with mobility issues
Smart Wearable Device (gaitQ) That Helps People With Long-term Conditions Affecting Movement: Walk Better
This study is testing a smart device that helps people with mobility issues, especially those with Parkinson's disease, improve their walking in everyday situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Exeter Academic / other |
| Locations | 1 site (Exeter) |
| Trial ID | NCT05913219 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the gaitQ smart cueing device designed to assist individuals with long-term mobility conditions, particularly those with Parkinson's disease. The study will refine the device's algorithms and monitoring systems while assessing its impact on gait improvement in both clinical and everyday environments. By utilizing a participatory design methodology and evidence-based research, the study seeks to identify factors that enhance mobility and the device's potential for broader adoption in rehabilitation settings.
Who should consider this trial
Good fit: Ideal candidates include adults with long-term mobility-affecting conditions such as Parkinson's disease, stroke, multiple sclerosis, arthritis, or osteoporosis.
Not a fit: Patients with acute mobility issues or those unable to walk unsupported for at least 3 minutes may not benefit from this study.
Why it matters
Potential benefit: If successful, this device could significantly enhance mobility and quality of life for patients with conditions like Parkinson's disease, stroke, and arthritis.
How similar studies have performed: While similar approaches have been explored, this specific smart cueing device represents a novel intervention in the field of mobility rehabilitation.
Eligibility criteria
Show full inclusion / exclusion criteria
Eligibility Criteria This research will investigate the impact of the gaitQ product on a sufficiently large cohort of PwP, healthy controls and other potential conditions such as stroke and hip and knee replacements. Inclusion criteria * Participants with long-term conditions affecting movement * Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition-specific scales \[stroke, multiple sclerosis, arthritis or osteoporosis\] * Able to self-report history of daily gait freezing and/or festination for people with PD or gait affected by condition * Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carry out this level of exercise * Adult (+18 years old) * Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support * Montreal Cognitive assessment score \>21 or ability to follow 2-stage commands * Healthy participants * With no long-term conditions affecting movement * Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise * Adult (+18 years old) * Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support * Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands 7.1.2 Exclusion criteria * Participants with long-term conditions affecting movement * Any physical or mental condition affecting the ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team. * Cognitive impairment affecting the ability to safely participate and follow instructions * Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition) * Any skin conditions or broken skin in the calf and behind the knee area * Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system * Healthy participants * Any physical or mental condition affecting the ability to safely participate in this level of activity and capacity to understand testing as demonstrated by the ability to safely follow commands and pass the PARQ by the research team. * Cognitive impairment affecting the ability to safely participate and follow instructions * Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition) * Any skin conditions or broken skin in the calf and behind the knee area * Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system
Where this trial is running
Exeter
- University of Exeter — Exeter, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Helen Dawes — Professor of Clinical Rehabilitations
- Study coordinator: Helen Dawes, PhD
- Email: h.dawes@exeter.ac.uk
- Phone: 01392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.